ersity in Wuhan, China
  Expanded Access Remdesivir (RDV; GS-5734TM)                                                                                                                                           Remdesivir                                                                                                                                                                                                                                                         Initiated            \-

The table represents a list of selected clinical trials for the amelioration of COVID-19 specific drugs and vaccines.

###### 

Details of currently available drugs in the treatment of COVID-19

  Name of Drug                                                                                                                   Illnesses treated
  ------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------
  Ribavirin                                                                                                                      RSV and RSV pneumonia
  Reverse transcriptase inhibitors: zidovudine, didanosine, zalcitabine, stavudine, lamivudine, abacavir and emtricitabine       SARS
  Cathespin L                                                                                                                    SARS
  Methylprednisolone                                                                                                             SARS, MERS
  Protease Inhibitors (PIs): saquinavir, ritonavir, indinavir, nelfinavir, amprenavir, lopinavir, atazanavir and fosamprenavir   SARS
  Fusion inhibitor: enfuvirtide. Lamivudine and adefovir dipivoxil                                                               SARS
  Baricitinib                                                                                              